Economic modelling: 'voodoo science' or useful tool?
Guidelines improve survival in unstable angina
Prodigy gives migraine sufferers a headache
Cost effectiveness of pneumococcal vaccine debatable
Clinical trials enhance physicians' product awareness
News in brief ...
PPI-based dual therapy not the best bet for H. pylori infection
Diabetes programme breaks even in first year
IFN-α-2b + ribavirin preferred initial treatment for hep C
Zanamivir good value for 'flu in high-risk Australians
Large savings claimed with CHF programme
Intervention to promote rational prescribing successful in the UK
Risk assessment for preterm birth cost saving?
News in brief ...
Gemcitabine preferable to etoposide for cisplatin-based NSCLC chemo
Antihypertensive use has doubled in Spain
News in brief ...
IVF: cost per delivery increases with age
News in brief ...
Milnacipran improves QOL in patients recovered from depression
Palliative chemotherapy in breast cancer: response-QOL link
Cut-price deal for TB drugs awaited
HMO forces drug price cuts
UK NHS 10-year blueprint revealed
News in brief ...
News in brief ...